Evidence map›Paper›PMID 40173048›Full record

ArticleJournal of periodontology2025

Comparison of four bone substitute types in sinus augmentation with perforated Schneiderian membrane: An experimental study.

Jung-Tae Lee, Seok Hyun Lee, Baek Sun Choi, Sungtae Kim

Abstract readComparative Study
In one paragraph

Article in Journal of periodontology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jung-Tae LeeDepartment of Periodontics, One-Stop Specialty Center, Seoul National University Dental Hospital, Jongno-gu, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0001-5383-3004
Seok Hyun LeeXenograft Development Team, Tissue Regeneration Institute, Osstem Implant Co. Ltd., Gangseo-gu, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-7473-9882
Baek Sun ChoiXenograft Development Team, Tissue Regeneration Institute, Osstem Implant Co. Ltd., Gangseo-gu, Seoul, Republic of Korea.ORCID https://orcid.org/0009-0002-7129-4846
Sungtae KimDepartment of Periodontology, Dental Research Institute, Seoul National University School of Dentistry, Jongno-gu, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0001-6361-4104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCollagenated bovine bone mineral (CBBM) is used for maxillary sinus elevation-based augmentation. We compared collagen degradation in cross-linked (CL) CBBM and non-cross-linked (NCL) CBBM (in vitro) and preclinical results in CBBM-CL, CBBM-NCL, deproteinized bovine bone mineral (DBBM), and DBBM with fibrin sealant grafts (in vivo) after repair of perforated Schneiderian membrane (SM).

methodsCollagenase-based degradation rates of CBBM-CL and CBBM-NCL were compared in vitro and in vivo (CBBM-CL, CBBM-NCL, DBBM, and DBBM with fibrin glue; n = 12 defects per group). After bilateral maxillary SM perforation (5 mm) during sinus elevation, we performed bone substitute-based augmentation. At 4 and 12 weeks postoperatively, volumetric, histologic, and histomorphometric analyses were performed.

resultsComplete degradation and 33% retention of collagen content after 24 and 72 h were noted in CBBM-NCL and CBBM-CL, respectively. CBBM-NCL demonstrated significant differences in total augmentation volume (TAV) compared to DBBM and DBBM with fibrin glue, as well as in new bone volume (NBV) compared to DBBM with fibrin glue. At 12 weeks, significant differences were observed between CBBM-NCL and DBBM in NBV. There were no significant differences across all groups in vertical bone increase in 4 and 12 weeks. DBBM and DBBM with fibrin glue showed more irregularly shaped patterns than CBBM-CL and CBBM-NCL. At 12 weeks, ossification progressed in all groups. At 4 weeks, DBBM with fibrin glue seemed to demonstrate early ossification at the perforation site in histological observations compared to DBBM alone; however, no differences were observed at 12 weeks.

conclusionCBBM for perforated SM repair confers bone stability and ossification. CBBM-CL was noninferior to CBBM-NCL in volume stability. The findings indicate that the CL collagen in CBBM-CL contributes to enhanced graft stability over time. Fibrin glue appeared to have a positive effect on early ossification in histological evaluations, but this effect was not evident at 12 weeks. PLAIN LANGUAGE SUMMARY: Collagenated bovine bone mineral (CBBM) is used for maxillary sinus elevation-based augmentation. We compared collagen degradation in cross-linked (CL) CBBM and non-cross-linked (NCL) CBBM (in vitro) and preclinical results in CBBM-CL, CBBM-NCL, deproteinized bovine bone mineral (DBBM), and DBBM with fibrin sealant (in vivo) after repair of perforated Schneiderian membrane (SM). After bilateral maxillary SM perforation (5 mm) during sinus elevation, we performed bone substitute-based augmentation. At 4 and 12 weeks postoperatively, volumetric, histologic, as well as histomorphometric analyses were performed. Based on this study, CL collagen in CBBM-CL contributes to enhanced graft stability over time. Fibrin glue appeared to have a positive effect on early ossification in histological evaluations, but this effect was not evident at 12 weeks.

Indexed as

Bone SubstitutesNasal MucosaSinus Floor AugmentationAnimalsBone MatrixCattleCollagenCollagenasesCross-Linking ReagentsFibrin Tissue AdhesiveMaleMaxillary SinusMineralsOsteogenesisBio-OssBone SubstitutesCollagenCollagenasesCross-Linking ReagentsFibrin Tissue AdhesiveMineralsbone graftbone regenerationfibrin tissue adhesivemaxillary sinusossification

Identifiers

PMID40173048
PMCPMC12572692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.